Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)
South Korea
· Delayed Price · Currency is KRW 11,830
+50 (0.42%)
Apr 29, 2026, 2:40 PM KST
KRX:019170 Revenue
In the year 2025, Shinpoong Pharmaceutical Co.,Ltd had annual revenue of 234.68B KRW with 6.15% growth. Shinpoong Pharmaceutical Co.,Ltd had revenue of 58.04B in the quarter ending December 31, 2025, with 5.03% growth.
Revenue
234.68B
Revenue Growth
+6.15%
P/S Ratio
2.61
Revenue / Employee
290.09M
Employees
809
Market Cap
611.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 234.68B | 13.59B | 6.15% |
| Dec 31, 2024 | 221.09B | 20.87B | 10.42% |
| Dec 31, 2023 | 200.23B | -9.06B | -4.33% |
| Dec 31, 2022 | 209.29B | 20.05B | 10.60% |
| Dec 31, 2021 | 189.24B | -8.51B | -4.31% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dong-A Socio Holdings | 1,429.77B |
| Bukwang Pharmaceutical | 200.71B |
| JW Pharmaceutical | 775.30B |
| EuBiologics | 96.04B |
| Huons Global | 847.45B |
| Boryung | 1,017.43B |
| Ildong Pharmaceutical | 566.93B |
| FutureChem Co.,Ltd | 18.67B |